184
Views
6
CrossRef citations to date
0
Altmetric
Cognition

Italian adaptation of the Beaumont Behavioral Inventory (BBI): psychometric properties and clinical usability

, , , , , , , , , , & show all
Pages 81-86 | Received 20 Apr 2021, Accepted 14 Jun 2021, Published online: 19 Jul 2021

References

  • Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456–77.
  • Strong MJ, Abrahams S, Goldstein LH, Woolley S, Mclaughlin P, Snowden J, et al. Amyotrophic lateral sclerosis – frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria . Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:153–74.
  • Raaphorst J, Beeldman E, De Visser M, De Haan RJ, Schmand B. A systematic review of behavioural changes in motor neuron disease. Amyotroph Lateral Scler. 2012;13:493–501.
  • Caga J, Hsieh S, Lillo P, Dudley K, Mioshi E. The impact of cognitive and behavioral symptoms on ALS patients and their caregivers. Front Neurol. 2019;10:192.
  • Huynh W, Ahmed R, Mahoney CJ, Nguyen C, Tu S, Caga J, et al. The impact of cognitive and behavioral impairment in amyotrophic lateral sclerosis. Expert Rev Neurother. 2020;20:281–93.
  • Gosselt IK, Nijboer TC, Van Es MA. An overview of screening instruments for cognition and behavior in patients with ALS: selecting the appropriate tool for clinical practice. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:324–36.
  • Simon N, Goldstein LH. Screening for cognitive and behavioral change in amyotrophic lateral sclerosis/motor neuron disease: a systematic review of validated screening methods. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:1–11.
  • Elamin M, Pinto-Grau M, Burke T, Bede P, Rooney J, O’Sullivan M, et al. Identifying behavioural changes in ALS: validation of the Beaumont Behavioural Inventory (BBI). Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:68–73.
  • Burke T, Pinto Grau M, Lonergan K, Bede P, O'Sullivan M, Heverin M, et al. A cross-sectional population-based investigation into behavioral change in amyotrophic lateral sclerosis: subphenotypes, staging, cognitive predictors, and survival. Ann Clin Transl Neurol. 2017;4:305–17.
  • Pinto-Grau M, Costello E, O’Connor S, Elamin M, Burke T, Heverin M, et al. Assessing behavioural changes in ALS: cross-validation of ALS-specific measures. J Neurol. 2017;264:1397–401.
  • Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
  • Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (PhaseIII). J Neurol Sci. 1999 Oct 31;169(1–2):13–21. doi: https://doi.org/10.1016/s0022-510x(99)00210-5. PMID: 10540002.
  • Appollonio I, Leone M, Isella V, Piamarta F, Consoli T, Villa ML, et al. The Frontal Assessment Battery (FAB): normative values in an Italian population sample. Neurol Sci. 2005;26:108–16.
  • Poletti B, Solca F, Carelli L, Madotto F, Lafronza A, Faini A, et al. The validation of the Italian Edinburgh cognitive and behavioural ALS screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:489–98.
  • Alberici A, Geroldi C, Cotelli M, Adorni A, Calabria M, Rossi G, et al. The Frontal Behavioural Inventory (Italian version) differentiates frontotemporal lobar degeneration variants from Alzheimer's disease. Neurol Sci. 2007;28:80–6.
  • Grace J, Stout J, Malloy P. Assessing frontal lobe behavioral syndromes with the frontal lobe personality scale. Assessment. 1999;6:269–84.
  • Costantini M, Musso M, Viterbori P, Bonci F, Del Mastro L, Garrone O, Venturini M, Morasso G. Detecting psychological distress in cancer patients: validity of the Italian version of the Hospital Anxiety and Depression Scale. Support Care Cancer. 1999 May;7(3):121–7. doi: https://doi.org/10.1007/s005200050241. PMID: 10335929
  • Chiò A, Vignola A, Mastro E, Giudici AD, Iazzolino B, Calvo A, et al. Neurobehavioral symptoms in ALS are negatively related to caregivers' burden and quality of life. Eur J Neurol. 2010;17:1298–303.
  • Gibbons CJ, Mills RJ, Thornton EW, Ealing J, Mitchell JD, Shaw PJ, et al. Rasch analysis of the hospital anxiety and depression scale (HADS) for use in motor neurone disease. Health Qual Life Outcomes. 2011;9:82–8.
  • Murphy J, Ahmed F, Lomen-Hoerth C. The UCSF screening exam effectively screens cognitive and behavioral impairment in patients with ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:24–30.
  • Kim HY. Statistical notes for clinical researchers: assessing normal distribution (2) using skewness and kurtosis. Restor Dent Endod. 2013;38:52–4.
  • Aiello EN, Depaoli EG, Gallucci M. Usability of the Negative Binomial model for analyzing ceiling and highly-inter-individually-variable cognitive data. Neurol Sci. 2020;41:S273–S4.
  • Fluss R, Faraggi D, Reiser B. Estimation of the Youden Index and its associated cutoff point. Biom J. 2005;47:458–72.
  • IBM Corp. (2020). IBM SPSS statistics for windows, version 27.0. Armonk, NY: IBM Corp.
  • Gallucci, M. (2019). GAMLj: General analyses for linear models [jamovi module]. Available at: https://gamlj.github.io/.
  • The Jamovi Project. ( 2020). Jamovi (version 1.6) [Computer Software]. Available at: https://www.jamovi.org.
  • Chiò A, Hammond ER, Mora G, Bonito V, Filippini G. Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2015;86:38–44.
  • Montuschi A, Iazzolino B, Calvo A, Moglia C, Lopiano L, Restagno G, et al. Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J Neurol Neurosurg Psychiatry. 2015;86:168–73.
  • McHugh ML. Interrater reliability: the kappa statistic. Biochem Med. 2012;22:276–82.
  • Chiò A, Moglia C, Canosa A, Manera U, Vasta R, Brunetti M, et al. Cognitive impairment across ALS clinical stages in a population-based cohort. Neurology. 2019;93:e984–94.
  • Yang T, Hou Y, Li C, Cao B, Cheng Y, Wei Q, et al. Risk factors for cognitive impairment in amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2021;92:688–93.
  • Zucchi E, Ticozzi N, Mandrioli J. Psychiatric symptoms in amyotrophic lateral sclerosis: beyond a motor neuron disorder. Front Neurosci. 2019;13:175.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.